close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

5.300 -0.030 (-0.56%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,265
Open 5.300
Bid (Size) 5.040 (100)
Ask (Size) 5.400 (300)
Prev. Close 5.330
Today's Range 5.300 - 5.300
52wk Range 2.960 - 11.96
Shares Outstanding 752,755
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NDRA Stock Alert: Halper Sadeh LLC is Investigating Whether ENDRA Life Sciences Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
From ENDRA Life Sciences Inc.
Via Business Wire

Performance

YTD
+23.5%
+23.5%
1 Month
-5.4%
-5.4%
3 Month
+14.0%
+14.0%
6 Month
+11.3%
+11.3%
1 Year
+51.0%
+51.0%

More News

Read More
News headline image
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
From ASP Isotopes Inc.
Via GlobeNewswire
ENDRA Life Sciences (NASDAQ: NDRA) Emerging Diagnostic Infrastructure Catalyst in MASLD as GLP-1 Boom Accelerates – See Other Active Stocks
Via AB Newswire
News headline image
Mojo SmallCap Watch: DGXX, PLUG, MNTS, NDRA, POET Driving AI, GLP-1 and Energy Trends
Via AB Newswire
Topics Artificial Intelligence Economy Energy
News headline image
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW!
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness
Via AB Newswire
News headline image
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences (NASDAQ: NDRA) Heats Up as Diagnostic Play Targeting GLP-1 Bottleneck – See Comparison Stocks Inside
Via AB Newswire
News headline image
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside
Via AB Newswire
News headline image
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Discover the top movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
Reversal Alert: VTIX, MARA, IBRX, BATL, NDRA, EEIQ Gain Momentum as Multi-Sector Catalysts Build
Via AB Newswire
News headline image
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now!
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
Via AB Newswire
News headline image
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA)
Via Get News
News headline image
NASDAQ March 2026: VTIX, ONDS, RUBI, NDRA, SOUN + Others – February’s Most Shorted Names Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
Stocks in the News: ALBT, NDRA, CURX, HCTI – AI, Clinical Milestones Drive Market Surges
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
From ENDRA Life Sciences Inc.
Via Business Wire

Frequently Asked Questions

Is ENDRA Life Sciences Inc. - Common Stock publicly traded?
Yes, ENDRA Life Sciences Inc. - Common Stock is publicly traded.
What exchange does ENDRA Life Sciences Inc. - Common Stock trade on?
ENDRA Life Sciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ENDRA Life Sciences Inc. - Common Stock?
The ticker symbol for ENDRA Life Sciences Inc. - Common Stock is NDRA on the Nasdaq Stock Market
What is the current price of ENDRA Life Sciences Inc. - Common Stock?
The current price of ENDRA Life Sciences Inc. - Common Stock is 5.300
When was ENDRA Life Sciences Inc. - Common Stock last traded?
The last trade of ENDRA Life Sciences Inc. - Common Stock was at 07/01/26 09:30 AM ET
What is the market capitalization of ENDRA Life Sciences Inc. - Common Stock?
The market capitalization of ENDRA Life Sciences Inc. - Common Stock is 3.99M
How many shares of ENDRA Life Sciences Inc. - Common Stock are outstanding?
ENDRA Life Sciences Inc. - Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today